Minerva Neurosciences Q2 EPS $(1.12) Misses $(0.44) Estimate; Cash, Cash Equivalents, And Restricted Cash Of $$51.9M
Portfolio Pulse from Benzinga Newsdesk
Minerva Neurosciences reported Q2 losses of $1.12 per share, missing the analyst consensus estimate of $0.44 by 154.55%. This is a 31.29% increase over losses from the same period last year. The company also reported cash, cash equivalents, and restricted cash of $51.9M.
August 01, 2023 | 11:54 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Minerva Neurosciences reported larger than expected losses for Q2, which could negatively impact investor sentiment.
Minerva Neurosciences reported a larger than expected loss for Q2, missing analyst estimates by a significant margin. This could lead to a negative reaction from investors and potentially a drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100